TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
NUVL

Nuvalent Inc

Healthcare · Biotechnology

124.00$ +0.0% vs. previous close Closing price · As of: Jul 21, 2026

Statements

Income Statement

Nuvalent Inc (NUVL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement NUVL
Line item 2019 2020 2021 2022 2023 2024 2025
0.0 0.0 0.0 0.0 0.0 0.0 0.0
9.7 15 36 64 113 218 307
0.6 1.5 10 22 36 63 107
10 17 46 86 149 280 414
-10 -17 -46 -86 -149 -280 -414
0.0 0.0 0.5 4.3 23 38
-12 -15 -46 -82 -126 -260 -425
1.5 -2.3 0.5 -8.5 -0.2 0.8 0.6
-12 -15 -46 -73 -126 -261 -425
-12 -15 -46 -78 -126 20 -10

Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?